Pulmonary embolism is a common cause of cardiovascular-associated morbidity and mortality. Although pulmonary embolism ...

The drug is currently being evaluated in three late-stage clinical trials, with a lead indication for prevention of stroke and systemic embolism in patients with irregular heart rhythm known as ...

Overall, however, the net clinical benefit—based on an endpoint incorporating all stroke and systemic embolism, MI, cardiovascular death, and major bleeding—tends to lean toward giving the DOAC versus ...

The objective of this study was to investigate the risk of acute internal jugular, subclavian, and axillary deep venous thrombosis (upper torso DVT [UTDVT]) and pulmonary embolism (PE) and the ...